Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Strict regulations may slow down new LLLT treatments.

Breast cancer patients need better psychological support to improve their quality of life.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Photodynamic therapy shows promise for oral lichen planus but needs more research for consistent results.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Patients with lichen planopilaris have a higher risk of heart disease.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Two genes, ERBB4 and ROR1, may cause the unique pigmentation in Lanping black-boned sheep.

Erosive palmoplantar lichen planus in North-East India mainly affects the feet and often involves nails, with unique inflammatory skin changes.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

Photobiomodulation Therapy (PBMT) is recommended as a more inclusive term and shows potential benefits in various treatments.

PP405 may help hair growth by activating hair follicle stem cells.

PRLR mutations affect cattle growth and hair weight in hot climates.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Low-level laser therapy can help with inflammation but isn't widely accepted yet.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

A new variant of lichen planopilaris causing diffuse hair thinning was identified.

Tofacitinib effectively improves lichen planus pigmentosus symptoms.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

The PIRL laser cuts tissue with less damage and scarring than traditional methods.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

Poly-L-lactic acid injections can cause hair loss and skin issues.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.